PRNewsWire - Health

REI Cooperative Action Fund announces spring 2025 grantees
Theravance Biopharma Announces Approval of YUPELRI® (revefenacin) by China's NMPA
Avivomed Names Dan Brounstein as Next Chief Executive Officer
Edgewise Therapeutics Reports Positive Results on Sevasemten Program for Becker and Duchenne Muscular Dystrophies